Rheumatology

Back to articles

Initiation of anti-TNF inhibitor does not increase herpes zoster risk

KEY POINT

Individuals with rheumatoid arthritis (RA) and other inflammatory diseases who initiated anti-tumor necrosis factor (anti-TNF) therapy were not at greater risk of herpes zoster infection than patients starting nonbiologic disease modifying antirheumatic drugs (DMARDs).